BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27061318)

  • 1. Clinical applications of MS-based protein quantification.
    Sabbagh B; Mindt S; Neumaier M; Findeisen P
    Proteomics Clin Appl; 2016 Apr; 10(4):323-45. PubMed ID: 27061318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography tandem mass spectrometry in the clinical laboratory.
    Adaway JE; Keevil BG; Owen LJ
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):18-38. PubMed ID: 25313226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].
    Saint-Marcoux F
    Ann Biol Clin (Paris); 2015; 73(1):49-53. PubMed ID: 25582722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.
    Marinova M; Artusi C; Brugnolo L; Antonelli G; Zaninotto M; Plebani M
    Clin Biochem; 2013 Nov; 46(16-17):1723-7. PubMed ID: 24012696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An introduction to drug testing: the expanding role of mass spectrometry.
    Hammett-Stabler C; Cotten SW
    Methods Mol Biol; 2012; 902():1-13. PubMed ID: 22767103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry.
    Dittrich J; Becker S; Hecht M; Ceglarek U
    Proteomics Clin Appl; 2015 Feb; 9(1-2):5-16. PubMed ID: 25418444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. After another decade: LC-MS/MS became routine in clinical diagnostics.
    Seger C; Salzmann L
    Clin Biochem; 2020 Aug; 82():2-11. PubMed ID: 32188572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the New RapidFire System for Therapeutic Monitoring of Immunosuppressants.
    Grote-Koska D; Czajkowski S; Brand K
    Ther Drug Monit; 2015 Jun; 37(3):400-4. PubMed ID: 25254418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.
    Yang Z; Wang S
    J Immunol Methods; 2008 Jul; 336(2):98-103. PubMed ID: 18547583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS for protein and peptide quantification in clinical chemistry.
    Rauh M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():59-67. PubMed ID: 22000960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput liquid chromatography-tandem mass spectrometric analysis of sirolimus in whole blood.
    Wallemacq PE; Vanbinst R; Asta S; Cooper DP
    Clin Chem Lab Med; 2003 Jul; 41(7):921-5. PubMed ID: 12940519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of immunosuppressant drugs].
    Rentsch KM
    Ther Umsch; 2008 Sep; 65(9):545-50. PubMed ID: 18791969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometry in Clinical Laboratory: Applications in Biomolecular Analysis.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1378():1-9. PubMed ID: 26602111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics Clinical Applications Reviews 2016.
    Dunn MJ
    Proteomics Clin Appl; 2016 Apr; 10(4):301. PubMed ID: 27061316
    [No Abstract]   [Full Text] [Related]  

  • 17. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.
    Taylor PJ; Tai CH; Franklin ME; Pillans PI
    Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics technologies for the global identification and quantification of proteins.
    Brewis IA; Brennan P
    Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted proteomics for the indirect detection of dexamethasone treatment in bovines.
    Stella R; Barrucci F; Angeletti R; James P; Montesissa C; Biancotto G
    Anal Bioanal Chem; 2016 Nov; 408(29):8343-8353. PubMed ID: 27695961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.